All material subject to strictly enforced copyright laws. © 2022 IFLR is part of the Euromoney Institutional Investor PLC group.

US lawsuit could force Chinese sovereign immunity changes

The referral of a US investment fund’s Hong Kong lawsuit to Beijing has prompted calls for China to amend its position on sovereign immunity

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login